Title 42, The Public Health and WelfareRelease 119-110

§289g–3 Breast Implant Research

Title 42 › CHAPTER 6A — PUBLIC HEALTH SERVICE › SUBCHAPTER III — NATIONAL RESEARCH INSTITUTES › Part H — General Provisions › § 289g–3

Last updated Sep 22, 2026|Official source

Summary

The NIH Director may run or fund research to study the long-term health effects of silicone breast implants, both gel and saline. Research can include creating ways to measure silicone levels in body fluids and tissues and tracking people with implants over time to see long-term results and local complications. Breast implant: a breast prosthesis implanted to augment or reconstruct the female breast.

Full Legal Text

Title 42, §289g–3

The Public Health and Welfare, Source: USLM XML via OLRC

(a)In general
The Director of NIH may conduct or support research to examine the long-term health implications of silicone breast implants, both gel and saline filled. Such research studies may include the following:
(1)Developing and examining techniques to measure concentrations of silicone in body fluids and tissues.
(2)Surveillance of recipients of silicone breast implants, including long-term outcomes and local complications.
(b)Definition
For purposes of this section, the term “breast implant” means a breast prosthesis that is implanted to augment or reconstruct the female breast.

Legislative History

Notes & Related Subsidiaries

Statutory Notes and Related Subsidiaries

Breast Implants; Study by Comptroller General Pub. L. 107–250, title II, § 214, Oct. 26, 2002, 116 Stat. 1615, which provided that the Comptroller General was to conduct a study of information typically provided by health professionals to women on breast implant surgery and to report the findings of the study to Congress, was repealed by Pub. L. 111–8, div. G, title I, § 1301(g), Mar. 11, 2009, 123 Stat. 829.

Reference

Citations & Metadata

Citation

42 U.S.C. § 289g–3

Title 42, The Public Health and Welfare

Last Updated

Sep 22, 2026

Release point: 119-110